Search
Generic filters

News

The Latest News from LGM Pharma

LGM Pharma Unveils Enhanced Analytical Testing Services and Expands CDMO Portfolio with Additional Suppository Manufacturing Capabilities
March 22, 2024
—50% expansion and over $2 million investment in standalone analytical testing services (ATS); offers...
LGM Pharma Reports Strong Revenues In First Year Of CDMO Operations Along With Continued Growth In Its API Sourcing Business
March 15, 2023
─CDMO Clinical and Commercial Manufacturing Services, Including Analytical Testing and Drug Product R&D...
LGM pharma’s unique mix of API sourcing and CDMO services is fueling robust growth
May 16, 2022
─Customer Projects Bridging LGM Pharma’s API Sourcing and CDMO Services Range from Promising Pharmaceutical...
LGM Pharma launches standalone analytical services for drug developers and manufacturers
July 08, 2021
─Analytical Testing and Stability Services Covering Both Drug Substance and Drug Product are Available...
NAI/Merin Hunter Codman negotiates 33,488 sf lease on behalf of Boca Raton’s LGM Pharma as part of their Nexgen Pharma acquisition
June 29, 2021
Boca Raton, FL & Irvine, CA RELEASE PDF– NAI/Merin Hunter Codman, a leading South Florida commercial...
LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma
July 23, 2020
LGM Pharma’s Expanded Contract Development and Manufacturing Organization (CDMO) Capabilities Will Enable...
How can we help?
Contact Us